Szudy-Szczyrek, A.; Bachanek-Mitura, O.; Gromek, T.; Chromik, K.; Mital, A.; Szczyrek, M.; Krupski, W.; Szumiło, J.; Kanduła, Z.; Helbig, G.;
et al. Real-World Efficacy of Midostaurin in Aggressive Systemic Mastocytosis. J. Clin. Med. 2021, 10, 1109.
https://doi.org/10.3390/jcm10051109
AMA Style
Szudy-Szczyrek A, Bachanek-Mitura O, Gromek T, Chromik K, Mital A, Szczyrek M, Krupski W, Szumiło J, Kanduła Z, Helbig G,
et al. Real-World Efficacy of Midostaurin in Aggressive Systemic Mastocytosis. Journal of Clinical Medicine. 2021; 10(5):1109.
https://doi.org/10.3390/jcm10051109
Chicago/Turabian Style
Szudy-Szczyrek, Aneta, Oliwia Bachanek-Mitura, Tomasz Gromek, Karolina Chromik, Andrzej Mital, Michał Szczyrek, Witold Krupski, Justyna Szumiło, Zuzanna Kanduła, Grzegorz Helbig,
and et al. 2021. "Real-World Efficacy of Midostaurin in Aggressive Systemic Mastocytosis" Journal of Clinical Medicine 10, no. 5: 1109.
https://doi.org/10.3390/jcm10051109
APA Style
Szudy-Szczyrek, A., Bachanek-Mitura, O., Gromek, T., Chromik, K., Mital, A., Szczyrek, M., Krupski, W., Szumiło, J., Kanduła, Z., Helbig, G., & Hus, M.
(2021). Real-World Efficacy of Midostaurin in Aggressive Systemic Mastocytosis. Journal of Clinical Medicine, 10(5), 1109.
https://doi.org/10.3390/jcm10051109
